Annual Gross Margin
49.16%
-6.79%-12.14%
April 30, 2024
Summary
- As of February 8, 2025, IPA annual gross profit margin is 49.16%, with the most recent change of -6.79% (-12.14%) on April 30, 2024.
- During the last 3 years, IPA annual gross margin has fallen by -15.25% (-23.68%).
- IPA annual gross margin is now -23.68% below its all-time high of 64.41%, reached on April 30, 2021.
Performance
IPA Gross Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Gross Margin
56.11%
+11.34%+25.33%
October 31, 2024
Summary
- As of February 8, 2025, IPA quarterly gross profit margin is 56.11%, with the most recent change of +11.34% (+25.33%) on October 31, 2024.
- Over the past year, IPA quarterly gross margin has increased by +11.34% (+25.33%).
- IPA quarterly gross margin is now -39.89% below its all-time high of 93.34%, reached on April 30, 2017.
Performance
IPA Quarterly Gross Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Gross Margin Formula
Gross Margin = Gross Profit
Revenue ✕ 100%
Revenue ✕ 100%
IPA Gross Margin Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -12.1% | +25.3% |
| 3 y3 years | -23.7% | +25.3% |
| 5 y5 years | +1.4% | +25.3% |
IPA Gross Margin Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -23.7% | at low | -11.3% | +25.3% |
| 5 y | 5-year | -23.7% | +1.4% | -28.9% | +25.3% |
| alltime | all time | -23.7% | +9.2% | -39.9% | +611.1% |
ImmunoPrecise Antibodies Gross Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Oct 2024 | - | 56.11%(+25.3%) |
| Jul 2024 | - | 44.77%(-7.0%) |
| Apr 2024 | 49.16%(-12.1%) | 48.12%(-6.4%) |
| Jan 2024 | - | 51.39%(+7.0%) |
| Oct 2023 | - | 48.03%(-2.3%) |
| Jul 2023 | - | 49.14%(-17.3%) |
| Apr 2023 | 55.95%(-1.4%) | 59.44%(+3.7%) |
| Jan 2023 | - | 57.32%(+6.9%) |
| Oct 2022 | - | 53.61%(+1.4%) |
| Jul 2022 | - | 52.87%(-16.5%) |
| Apr 2022 | 56.72%(-11.9%) | 63.29%(+17.8%) |
| Jan 2022 | - | 53.71%(-1.5%) |
| Oct 2021 | - | 54.53%(-0.2%) |
| Jul 2021 | - | 54.62%(-4.1%) |
| Apr 2021 | 64.41% | 56.94%(-27.8%) |
| Jan 2021 | - | 78.89%(+34.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Oct 2020 | - | 58.65%(-8.4%) |
| Jul 2020 | - | 64.01%(+36.5%) |
| Apr 2020 | 57.15%(+17.9%) | 46.90%(-14.9%) |
| Jan 2020 | - | 55.12%(-30.0%) |
| Oct 2019 | - | 78.74%(+55.4%) |
| Jul 2019 | - | 50.68%(+134.4%) |
| Apr 2019 | 48.46%(+7.6%) | 21.62%(-62.8%) |
| Jan 2019 | - | 58.17%(+12.8%) |
| Oct 2018 | - | 51.59%(-5.5%) |
| Jul 2018 | - | 54.58%(+34.3%) |
| Apr 2018 | 45.04%(-16.6%) | 40.64%(-29.2%) |
| Jan 2018 | - | 57.40%(+41.7%) |
| Oct 2017 | - | 40.51%(+413.4%) |
| Jul 2017 | - | 7.89%(-91.5%) |
| Apr 2017 | 54.01% | 93.34%(+282.1%) |
| Jan 2017 | - | 24.43% |
FAQ
- What is ImmunoPrecise Antibodies annual gross profit margin?
- What is the all time high annual gross margin for ImmunoPrecise Antibodies?
- What is ImmunoPrecise Antibodies annual gross margin year-on-year change?
- What is ImmunoPrecise Antibodies quarterly gross profit margin?
- What is the all time high quarterly gross margin for ImmunoPrecise Antibodies?
- What is ImmunoPrecise Antibodies quarterly gross margin year-on-year change?
What is ImmunoPrecise Antibodies annual gross profit margin?
The current annual gross margin of IPA is 49.16%
What is the all time high annual gross margin for ImmunoPrecise Antibodies?
ImmunoPrecise Antibodies all-time high annual gross profit margin is 64.41%
What is ImmunoPrecise Antibodies annual gross margin year-on-year change?
Over the past year, IPA annual gross profit margin has changed by -6.79% (-12.14%)
What is ImmunoPrecise Antibodies quarterly gross profit margin?
The current quarterly gross margin of IPA is 56.11%
What is the all time high quarterly gross margin for ImmunoPrecise Antibodies?
ImmunoPrecise Antibodies all-time high quarterly gross profit margin is 93.34%
What is ImmunoPrecise Antibodies quarterly gross margin year-on-year change?
Over the past year, IPA quarterly gross profit margin has changed by +11.34% (+25.33%)